These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8774690)

  • 1. Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein.
    Hicks KE; Cubel RC; Cohen BJ; Clewley JP
    Arch Virol; 1996; 141(7):1319-27. PubMed ID: 8774690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of parvovirus B19 NS1-specific antibodies by ELISA and western blotting employing recombinant NS1 protein as antigen.
    Heegaard ED; Rasksen CJ; Christensen J
    J Med Virol; 2002 Jul; 67(3):375-83. PubMed ID: 12116031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19.
    Heegaard ED; Qvortrup K; Christensen J
    J Med Virol; 2002 Feb; 66(2):246-52. PubMed ID: 11782935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of B-cell epitopes on human parvovirus B19 non-structural and structural proteins.
    Tolfvenstam T; Lundqvist A; Levi M; Wahren B; Broliden K
    Vaccine; 2000 Nov; 19(7-8):758-63. PubMed ID: 11115697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC
    J Virol Methods; 1995 Sep; 55(1):67-82. PubMed ID: 8576310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of neutralizing human monoclonal antibodies against parvovirus B19 proteins.
    Gigler A; Dorsch S; Hemauer A; Williams C; Kim S; Young NS; Zolla-Pazner S; Wolf H; Gorny MK; Modrow S
    J Virol; 1999 Mar; 73(3):1974-9. PubMed ID: 9971777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preparation of human parvovirus B19 virus-like particles].
    Zou X; Dong L; Song J; Qu J; Yu X; Lu Z; Hong T
    Sheng Wu Gong Cheng Xue Bao; 2009 Apr; 25(4):575-9. PubMed ID: 19637634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
    Ekman A; Hokynar K; Kakkola L; Kantola K; Hedman L; Bondén H; Gessner M; Aberham C; Norja P; Miettinen S; Hedman K; Söderlund-Venermo M
    J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variability among different parvovirus B19 isolates.
    Hemauer A; von Poblotzki A; Gigler A; Cassinotti P; Siegl G; Wolf H; Modrow S
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1781-5. PubMed ID: 8760426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long term follow up of serostatus after maternofetal parvovirus B19 infection.
    Dembinski J; Eis-Hübinger AM; Maar J; Schild R; Bartmann P
    Arch Dis Child; 2003 Mar; 88(3):219-21. PubMed ID: 12598382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions.
    Kajigaya S; Fujii H; Field A; Anderson S; Rosenfeld S; Anderson LJ; Shimada T; Young NS
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4646-50. PubMed ID: 1711206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most of the VP1 unique region of B19 parvovirus is on the capsid surface.
    Kawase M; Momoeda M; Young NS; Kajigaya S
    Virology; 1995 Aug; 211(2):359-66. PubMed ID: 7544049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis.
    von Poblotzki A; Hemauer A; Gigler A; Puchhammer-Stöckl E; Heinz FX; Pont J; Laczika K; Wolf H; Modrow S
    J Infect Dis; 1995 Nov; 172(5):1356-9. PubMed ID: 7594677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parvovirus B19 VP2-proteins produced in Saccharomyces cerevisiae: comparison with VP2-particles produced by baculovirus-derived vectors.
    Lowin T; Raab U; Schroeder J; Franssila R; Modrow S
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):348-52. PubMed ID: 16316399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to parvovirus B19 NS-1 protein in infected individuals.
    von Poblotzki A; Gigler A; Lang B; Wolf H; Modrow S
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():519-27. PubMed ID: 7534811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extent of sequence variability in a genomic region coding for capsid proteins of B19 parvovirus.
    Gallinella G; Venturoli S; Gentilomi G; Musiani M; Zerbini M
    Arch Virol; 1995; 140(6):1119-25. PubMed ID: 7611882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins.
    Brown CS; Van Lent JW; Vlak JM; Spaan WJ
    J Virol; 1991 May; 65(5):2702-6. PubMed ID: 1901917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection.
    Kerr JR; Coyle PV; DeLeys RJ; Patterson CC
    J Med Virol; 1996 Jan; 48(1):68-75. PubMed ID: 8825713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Aleutian mink disease parvovirus proteins in a baculovirus vector system.
    Christensen J; Storgaard T; Bloch B; Alexandersen S; Aasted B
    J Virol; 1993 Jan; 67(1):229-38. PubMed ID: 8380073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein.
    Wong S; Momoeda M; Field A; Kajigaya S; Young NS
    J Virol; 1994 Jul; 68(7):4690-4. PubMed ID: 8207846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.